Tyler S Kaster - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Tyler S Kaster

Showing results (31-40 of 50) with videos related to

Pageof 5

Sort By:

Schizophrenia Research|May 11, 2015

Clozapine potentiation of GABA mediated cortical inhibition in treatment resistant schizophreniaTyler S Kaster, Danilo de Jesus, Natasha Radhu, et al.

Brain Stimulation|April 19, 2024

Depressive symptom trajectories with prolonged rTMS treatmentXiao Chen, Daniel M Blumberger, Jonathan Downar, et al.

Frontiers in Psychiatry|February 2, 2018

Magnetic Seizure Therapy in Treatment-Resistant Schizophrenia: A Pilot StudyVictor M Tang, Daniel M Blumberger, Shawn M McClintock, et al.

JAMA Network Open|February 27, 2025

Tolerability and Clinical Outcomes With Anesthesia Dose Reduction During Electroconvulsive TherapyCaroline W Espinola, Tyler S Kaster, Jake Prillo, et al.

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 12, 2024

Clinical Characteristics of Inpatients with Schizophrenia Spectrum Disorder Treated with Electroconvulsive Therapy: A Population-Level Cross-Sectional Study: Titre: Caractéristiques cliniques des patients hospitalisés présentant un trouble du spectre de la schizophrénie et traités par électrochocs : Une étude de population transversaleTyler S Kaster, Amreen Babujee, Isobel Sharpe, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 22, 2020

Distinct trajectories of response to prefrontal tDCS in major depression: results from a 3-arm randomized controlled trialStephan A Goerigk, Frank Padberg, Markus Bühner, et al.

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 3, 2025

Mortality risk among people receiving acute hospital care for hallucinogen use compared with the general populationDaniel T Myran, Jennifer Xiao, Nicholas Fabiano, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 28, 2018

Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trialTyler S Kaster, Zafiris J Daskalakis, Yoshihiro Noda, et al.

Brain Stimulation|November 3, 2025

Trajectories of response to bilateral rTMS in late-life depressionErin Adler, Daniel M Blumberger, Xiao Chen, et al.

JAMA Psychiatry|November 13, 2024

Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum DisorderDaniel T Myran, Michael Pugliese, Jennifer Xiao, et al.

Pageof 5

Search research articles

Showing results (31-40 of 50) with videos related to

Sort By:

Pageof 5

Schizophrenia Research|May 11, 2015

Clozapine potentiation of GABA mediated cortical inhibition in treatment resistant schizophreniaTyler S Kaster, Danilo de Jesus, Natasha Radhu, et al.

Brain Stimulation|April 19, 2024

Depressive symptom trajectories with prolonged rTMS treatmentXiao Chen, Daniel M Blumberger, Jonathan Downar, et al.

Frontiers in Psychiatry|February 2, 2018

Magnetic Seizure Therapy in Treatment-Resistant Schizophrenia: A Pilot StudyVictor M Tang, Daniel M Blumberger, Shawn M McClintock, et al.

JAMA Network Open|February 27, 2025

Tolerability and Clinical Outcomes With Anesthesia Dose Reduction During Electroconvulsive TherapyCaroline W Espinola, Tyler S Kaster, Jake Prillo, et al.

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 12, 2024

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 22, 2020

Distinct trajectories of response to prefrontal tDCS in major depression: results from a 3-arm randomized controlled trialStephan A Goerigk, Frank Padberg, Markus Bühner, et al.

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 3, 2025

Mortality risk among people receiving acute hospital care for hallucinogen use compared with the general populationDaniel T Myran, Jennifer Xiao, Nicholas Fabiano, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 28, 2018

Brain Stimulation|November 3, 2025

Trajectories of response to bilateral rTMS in late-life depressionErin Adler, Daniel M Blumberger, Xiao Chen, et al.

JAMA Psychiatry|November 13, 2024

Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum DisorderDaniel T Myran, Michael Pugliese, Jennifer Xiao, et al.

Pageof 5